The ex-pharma exec leading Trump’s COVID-19 vaccine program has $10 million in stock options for a company getting federal funding

Dr Moncef Slaoui was named Chief Scientist for Trump’s “Operation Warp Speed” — but continues to have a large investment in Moderna, Inc.